Enroll in this course to get accessYou don't currently have access to this contentYou don't currently have access to this contentYou don't currently have access to this contentYou don't currently have access to this contentYou don't currently have access to this contentYou don't currently have access to this contentYou don't currently have access to this contentYou don't currently have access to this contentYou don't currently have access to this contentYou don't currently have access to this contentYou don't currently have access to this contentYou don't currently have access to this contentYou don't currently have access to this contentYou don't currently have access to this contentYou don't currently have access to this contentYou don't currently have access to this contentYou don't currently have access to this contentYou don't currently have access to this contentYou don't currently have access to this contentYou don't currently have access to this content
Current Status
Not Enrolled
Price
Free
Get Started

Global ASCVD Trends and Emerging Strategies

Vídeo 3: Farmacoterapias para obesidade e prevenção de DCV

Video 3: Pharmacotherapies for Obesity and CVD Prevention

Vídeo 2: Obesidade e Lesão em Órgãos-Alvo

Video 2: Obesity and Target Organ Damage

Vídeo 1: Epidemiologia da Obesidade e Doença Cardiovascular

Video 1: Epidemiology and Pathophysiology of Obesity and CVD

SESSÃO DE ABERTURA: Manejo da Obesidade – A Perspectiva do Paciente e do Provedor

Video 1: Epidemiology and pathophysiology of obesity and CVD

Part 4: Round table with the experts: Where do we stand in our battle against the ravages of diabetes?

Part 3 – Session B: Therapeutic options for prevention of cardiovascular disease

Part 3 – Session A: A Hierarchy of Treatment Approaches based on Severity for the T2DM Patient with ASCVD

Part 2: Combating Atherosclerosis: Assessing CV Patient Risk for the T2DM Patient

Part 1: The History in the Battle of Insulin and Glucagon

Parte 4, Mesa redonda com os especialistas – Onde estamos em nossa batalha contra os danos do diabetes?

Parte 3, Sessão B – Opções terapêuticas para prevenção de doenças cardiovasculares

« » page 1 / 14